Alliance for Clinical Trials in Oncology: Leukemia, Lymphoid trials
The registry lists 11 Leukemia, Lymphoid studies with Alliance for Clinical Trials in Oncology as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 2 6Phase 3 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01027000Phase 2Results posted
- Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaTerminatedNCT00513747Phase 3Results posted
- Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple MyelomaCompletedNCT03870633
- Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic LeukemiaCompletedNCT01284010
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT01005368
- Cytogenetic Studies in Acute Leukemia and Multiple MyelomaActive, not recruitingNCT00048958
- Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic LeukemiaCompletedNCT00005829Phase 2
- Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00004857Phase 2
- Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00003829Phase 2
- Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00003700Phase 2
- Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic LeukemiaCompletedNCT00003248Phase 2